in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
73<br />
5-HT 7 - agonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 0144<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
ExpresS Profile<br />
High-throughput profile<br />
BioPr<strong>in</strong>t ® profile<br />
Organ safety profile<br />
Source<br />
Ligand<br />
Kd<br />
Non specific<br />
Reference<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
[ 3 H]LSD (4 nM)<br />
2.3 nM<br />
seroton<strong>in</strong> (10 µM)<br />
seroton<strong>in</strong> (IC 50 : 0.45 nM)<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
50<br />
0<br />
-11 -10 -9 -8 -7 -6 -5 -4<br />
seroton<strong>in</strong> ❚<br />
log [drug] (M)<br />
Shen, Y. et al. (1993) J. Biol. Chem., 268: 18200-18204.<br />
[custom offer] rat cDNA model (Ref. 0143), please contact us at customresearch@cerep.com<br />
seroton<strong>in</strong><br />
8-OH-DPAT<br />
ketanser<strong>in</strong><br />
MDL 72222<br />
<strong>Cerep</strong><br />
services<br />
<br />
Receptors<br />
[GPCRs]<br />
5-HT 7<br />
cellul ar<br />
Ref. 1661<br />
Ref. 1662<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Agonist effect<br />
Antagonist effect<br />
Cellular functional GPCR profile<br />
Source<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
Measured product cAMP<br />
Detection method HTRF<br />
Agonist effect Control seroton<strong>in</strong> (10 µM)<br />
Reference seroton<strong>in</strong> (EC 50 : 25 nM)<br />
Antagonist effect Stimulant seroton<strong>in</strong> (300 nM)<br />
Reference mesulerg<strong>in</strong>e (IC 50 : 25 nM)<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Adham, N. et al. (1998) J. Pharmacol. Exp. Ther., 287: 508-514.<br />
❚ See other Seroton<strong>in</strong> assays pp. 91, 101 and 105<br />
<br />
❚ For sigma assays, see "Other receptors", <br />
page 91<br />
<br />
<br />
<br />
Ion<br />
channels<br />
Transporters<br />
❚ somatostat<strong>in</strong><br />
<br />
<br />
K<strong>in</strong>ases<br />
<br />
<br />
<br />
sst (non-selective) - agonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 0149<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
ExpresS Profile<br />
High-throughput profile<br />
Source<br />
Ligand<br />
Kd<br />
Non specific<br />
Reference<br />
AtT-20 cells<br />
[ 125 I]Tyr 11 -somatostat<strong>in</strong>-14 (0.05 nM)<br />
0.08 nM<br />
somatostat<strong>in</strong>-14 (300 nM)<br />
somatostat<strong>in</strong>-14 (IC 50 : 0.2 nM)<br />
Brown, P.J. et al. (1990) J. Biol. Chem., 265: 17995-18004.<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
50<br />
0<br />
-12 -11 -10 -9 -8 -7<br />
log [drug] (M)<br />
somatostat<strong>in</strong>-14<br />
[D-Trp 8 ]-<br />
somatostat<strong>in</strong><br />
somatostat<strong>in</strong>-28<br />
BIM 23056<br />
Epigenetic &<br />
DNA-related<br />
enzymes<br />
Other<br />
enzymes<br />
sst 1 - agonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 1940<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
BioPr<strong>in</strong>t ® profile<br />
Organ safety profile<br />
Source<br />
Ligand<br />
Kd<br />
Non specific<br />
Reference<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
[ 125 I]Tyr 11 -somatostat<strong>in</strong>-14 (0.1 nM)<br />
1nM<br />
somatostat<strong>in</strong>-28 (1 µM)<br />
somatostat<strong>in</strong>-28 (IC 50 : 0.5 nM)<br />
Patel, C.Y. and Srikant, C.B. (1994) Endocr<strong>in</strong>ology, 135: 2814-2817.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Specialized<br />
cellular<br />
assays<br />
Standard<br />
profiles<br />
sst 1<br />
cellul ar<br />
Ref. 2253<br />
Ref. 2254<br />
Q 3 weeks<br />
Agonist effect<br />
Antagonist effect<br />
Source<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
Measured product cAMP<br />
Detection method HTRF<br />
Agonist effect Control somatostat<strong>in</strong>-28 (100 nM)<br />
Reference somatostat<strong>in</strong>-28 (EC 50 : 0.37 nM)<br />
Antagonist effect Stimulant somatostat<strong>in</strong>-28 (3 nM)<br />
Reference unavailable<br />
Patel, Y.C. and Srikant, C.B. (1994) Endocr<strong>in</strong>ology, 135: 2814-2817.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
[Solvent] must be kept 0.3%<br />
<br />
<br />
Test<strong>in</strong>g<br />
conditions<br />
Order<strong>in</strong>g<br />
<strong>in</strong>formation<br />
<br />
<br />
<br />
For further details and updated <strong>in</strong>formation on assays:<br />
❚ Please go to www.cerep.com catalog onl<strong>in</strong>e or contact us at sales@cerep.com<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
❚ Europe: +33 (0)5 49 89 30 00 – USA: +1 (425) 895 8666 – Japan: +81 (0)3 3354 4026 – Ch<strong>in</strong>a: +86 21 5132 0568<br />
Assay developed <strong>in</strong> 2010 New assay conditions Human Q Standard turnaround time<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Assay list<br />
& <strong>in</strong>dex